Barrett's oesophagus in systemic sclerosis [1]

Alimentary Pharmacology and Therapeutics

Volumn 25, Issue 7, 2007, Pages 857-

  Wipff, J ^a   Allanore, Y ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BARRETT ESOPHAGUS; DYSPHAGIA; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGITIS; ESOPHAGUS MOTILITY; HELICOBACTER PYLORI; HUMAN; LETTER; MANOMETRY; NAUSEA AND VOMITING; PREVALENCE; PRIORITY JOURNAL; SYSTEMIC SCLEROSIS;

BARRETT ESOPHAGUS; ESOPHAGITIS; HUMANS; SCLERODERMA, SYSTEMIC;

EID: 33947212506     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2007.03257.x     Document Type: Letter

References (5)

1. Marie I, Ducrotte P, Denis P, et al. Oesophageal mucosal involvement in patients with systemic sclerosis receiving proton pump inhibitor therapy. Aliment Pharmacol Ther 2006; 24: 1593-601.
2. Wipff J, Allanore Y, Soussi F, et al. Prevalence of Barrett's esophagus in systemic sclerosis. Arthritis Rheum 2005; 52: 2882-8.
3. Bonino JA, Sharma P. Barrett's esophagus. Curr Opin Gastroenterol 2006; 22: 406-11.
4. Alonso O, Hernadez G, Moreno E, et al. The real value of lower esophageal sphincter measurement for predicting acid gastroesophageal reflux or Barrett's esophagus. J Gastrointest Surg 2005; 9: 973-9.
5. Derk CT, Rasheed M, Artlett M, et al. A cohort study of cancer incidence in systemic sclerosis. J Rheumatol 2006; 33: 1113-6.